We aimed to identify the frequency and costs of, and the disease predictors and inpatient process issues that may predispose to, 30-day readmission for an inflammatory bowel disease (IBD) patient.
Publication
The American journal of gastroenterology, 2013, Vol 108, Issue 7, p1024